» Authors » Amy L Peterson

Amy L Peterson

Explore the profile of Amy L Peterson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 341
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
First M, Reilly K, Zhang X, Peterson A
Pediatr Cardiol . 2024 Nov; PMID: 39592502
In order to evaluate the impact of a child's proximity to an urban center on their cardiometabolic health status and their response to treatment of cardiometabolic risk factors, retrospective review...
2.
Lentz M, Benoy M, Zhang X, Peterson A
J Clin Lipidol . 2024 Jun; 18(4):e620-e624. PMID: 38942689
Heterozygous familial hypercholesterolemia (HeFH) is an autosomal dominant disorder causing elevated low density lipoprotein cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease. Universal cholesterol screening in childhood leads to children serving...
3.
Gidding S, Ballantyne C, Cuchel M, de Ferranti S, Hudgins L, Jamison A, et al.
Glob Heart . 2024 May; 19(1):43. PMID: 38708402
Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that affects approximately one in 300,000 people. The disorder is characterized by extremely high, life-threatening levels of low-density lipoprotein (LDL) cholesterol...
4.
Shao X, Steiner R, Peterson A
Curr Opin Lipidol . 2024 Feb; 35(3):149-156. PMID: 38408035
Purpose Of Review: Newborn screening is one of the most successful public health programs of the last century and offers unparalleled access to universal screening for a variety of metabolic...
5.
McGowan M, Peterson A
J Pediatr . 2024 Feb; 268:113928. PMID: 38307324
No abstract available.
6.
Perak A, Baker-Smith C, Hayman L, Khoury M, Peterson A, Ware A, et al.
Circ Cardiovasc Qual Outcomes . 2023 Aug; 16(9):e000120. PMID: 37548024
Cardiovascular disease risk factors are highly prevalent among youth in the United States and Canada. Pediatric preventive cardiology programs have independently developed and proliferated to address cardiovascular risk factors in...
7.
Zawacki A, Enright C, Harris R, Dodge A, Peterson A
J Pediatr X . 2023 Jun; 4:100037. PMID: 37334253
Objectives: To measure case detection and response time of severe pediatric dyslipidemia, defined as non-high-density lipoprotein cholesterol (HDL-C) ≥190 mg/dL on the initial screening panel. Although low adherence to guidelines...
8.
Held P, Lasarev M, Zhang X, Wiberley-Bradford A, Campbell K, Horner V, et al.
J Pediatr . 2023 May; 259:113469. PMID: 37182660
Objective: To evaluate distribution profiles of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (apoB) as candidate markers of familial hypercholesterolemia in newborns, taking into consideration potential confounding...
9.
Spear J, Grabowski M, Sekhavati Y, Costa C, Goldstein D, Petrullo L, et al.
J Hum Evol . 2023 Apr; 179:103359. PMID: 37099927
The primate vertebral column has been extensively studied, with a particular focus on hominoid primates and the last common ancestor of humans and chimpanzees. The number of vertebrae in hominoids-up...
10.
Tobik K, Orland K, Zhang X, Garcia K, Peterson A
Matern Child Health J . 2023 Mar; 27(6):978-983. PMID: 36964843
Background: Familial hypercholesterolemia (FH) is an inherited disease which causes premature atherosclerotic cardiovascular disease. However, less than 10% of individuals with FH have been identified. Objective: To assess parental perspectives...